Arcturus Therapeutics Holdings reported revenue of $2.96M and net income of -$23.79M for the quarter ended Jun 2026, down 89.5% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 2.44M | 5.79M | 5.24M | 27.09M | 13.37M | 160.29M | 80.28M | 10.52M | 45.14M | 30.86M | 38.01M | 49.86M | 41.67M | 22.77M | 29.38M | 28.30M | 17.15M | 7.20M | 2.06M | 2.96M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 45.40M | 32.63M | 44.89M | 38.19M | 37.69M | 26.98M | 51.77M | 52.67M | 51.08M | 36.62M | 53.57M | 58.67M | 39.13M | 43.78M | 34.89M | 29.58M | 23.27M | 24.48M | 21.53M | 17.52M | |||||||||||||
| Selling, General & AdministrativeSG&A | 10.86M | 10.81M | 10.73M | 10.99M | 12.49M | 11.86M | 13.76M | 13.22M | 13.38M | 12.51M | 14.85M | 12.32M | 13.28M | 12.38M | 11.31M | 10.34M | 10.40M | 14.03M | 9.46M | 10.99M | |||||||||||||
| Operating ExpensesOpex | 56.26M | 43.44M | 55.62M | 49.18M | 50.18M | 38.84M | 65.53M | 65.89M | 64.45M | 49.13M | 68.42M | 70.98M | 52.41M | 56.16M | 46.21M | 39.92M | 33.66M | 38.50M | 30.99M | 28.50M | |||||||||||||
| Operating IncomeOp. Inc | -53.82M | -37.65M | -50.38M | -22.09M | -36.81M | 121.45M | 14.76M | -55.37M | -19.31M | -18.27M | -30.41M | -21.13M | -10.74M | -33.39M | -16.83M | -11.62M | -16.51M | -31.31M | -28.93M | -25.55M | |||||||||||||
| EBIT | -53.82M | -37.65M | -50.38M | -22.09M | -36.81M | 121.45M | 14.76M | -55.37M | -19.31M | -18.27M | -30.41M | -21.13M | -10.74M | -33.39M | -16.83M | -11.62M | -16.51M | -31.31M | -28.93M | -25.55M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | |||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.52M | -0.52M | -0.56M | 1.22M | 1.86M | -3.83M | 33.95M | 3.25M | 3.98M | 4.02M | 4.15M | 3.82M | 3.21M | -0.02M | -0.13M | 3.23M | 1.52M | 0.04M | -0.06M | ||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -53.82M | -37.65M | -51.17M | -21.56M | -35.27M | 118.64M | 50.86M | -51.97M | -15.33M | -11.45M | -26.45M | -17.37M | -7.12M | -30.01M | -14.08M | -9.18M | -13.45M | -29.08M | -28.93M | -23.79M | |||||||||||||
| Tax ProvisionsTaxes | 0.10M | 0.10M | 0.60M | 0.90M | 0.23M | 0.40M | -0.20M | -0.22M | -0.00M | 0.00M | -0.02M | ||||||||||||||||||||||
| Profit After TaxPAT | -54.08M | -38.66M | -51.17M | -21.56M | -35.27M | 117.35M | 50.75M | -52.55M | -16.22M | -11.71M | -26.82M | -17.22M | -6.90M | -30.00M | -14.08M | -9.18M | -13.45M | -29.08M | -26.96M | -23.79M | |||||||||||||
| Equity Income | -0.25M | -0.15M | -0.38M | -0.13M | |||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -53.82M | -37.65M | -51.27M | -21.56M | -35.27M | 118.64M | 50.75M | -52.57M | -16.23M | -11.68M | -26.85M | -17.17M | -6.90M | -30.00M | -14.08M | -9.18M | -13.45M | -29.07M | -28.93M | -23.79M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -53.82M | -37.65M | -51.27M | -21.56M | -35.27M | 118.64M | 50.75M | -52.57M | -16.23M | -11.68M | -26.85M | -17.17M | -6.90M | -30.00M | -14.08M | -9.18M | -13.45M | -29.07M | -28.93M | -23.79M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -53.82M | -37.65M | -51.27M | -21.56M | -35.27M | 118.64M | 50.75M | -52.57M | -16.23M | -11.68M | -26.85M | -17.17M | -6.90M | -30.00M | -14.08M | -9.18M | -13.45M | -29.07M | -28.93M | -23.79M | |||||||||||||
| Net Income towards Common StockholdersNet Income | -53.82M | -37.65M | -51.27M | -21.56M | -35.27M | 118.64M | 50.75M | -52.57M | -16.23M | -11.68M | -26.85M | -17.17M | -6.90M | -30.00M | -14.08M | -9.18M | -13.45M | -29.07M | -28.93M | -23.79M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -2.04 | -1.43 | -1.94 | -0.82 | -1.33 | 4.49 | 1.91 | -1.98 | -0.61 | -0.44 | -1.00 | -0.64 | -0.26 | -1.11 | -0.52 | -0.34 | -0.49 | -1.06 | -1.02 | -0.84 | |||||||||||||
| EPS (Diluted) | -2.04 | -1.43 | -1.94 | -0.82 | -1.33 | 4.38 | 1.87 | -1.98 | -0.61 | -0.44 | -1.00 | -0.64 | -0.26 | -1.11 | -0.52 | -0.34 | -0.49 | -1.06 | -1.02 | -0.84 | |||||||||||||
| Shares Outstanding | 26.34M | 26.32M | 26.38M | 26.43M | 26.47M | 26.45M | 26.55M | 26.56M | 26.57M | 26.63M | 26.88M | 26.97M | 27.06M | 27.00M | 27.11M | 27.13M | 27.19M | 27.39M | 28.42M | 28.42M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 26.34M | 26.32M | 26.38M | 26.43M | 26.47M | 27.09M | 27.15M | 26.56M | 26.57M | 26.63M | 26.88M | 26.97M | 27.06M | 27.00M | 27.11M | 27.13M | 27.19M | 27.39M | 28.42M | 28.42M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 26.35M | 26.37M | 26.41M | 26.43M | 26.49M | 26.55M | 26.55M | 26.57M | 26.72M | 26.83M | 26.92M | 27.04M | 27.08M | 27.10M | 27.12M | 27.15M | 27.23M | 28.41M | 28.42M | 28.42M | |||||||||||||
| EBITDA | -53.82M | -37.65M | -50.38M | -22.09M | -36.81M | 121.45M | 14.76M | -55.37M | -19.31M | -18.27M | -30.41M | -21.13M | -10.74M | -33.39M | -16.83M | -11.62M | -16.51M | -31.31M | -28.93M | -25.55M | |||||||||||||
| Tax Rate | -0.20% | 0.20% | -1.15% | -5.87% | -2.05% | -1.51% | 1.15% | 3.05% | 0.01% | -0.04% | 0.06% |